Literature DB >> 22150598

Optical coherence tomography for retinal metastasis with unknown primary tumor.

Marco Coassin1, Katayoon B Ebrahimi, Joan M O'Brien, Jay M Stewart.   

Abstract

The authors describe the optical coherence tomography (OCT) findings and the therapeutic approach of a patient with metastatic neoplastic disease of the retina. A patient with a history of brain cancer of undetermined origin underwent imaging and surgery to investigate a suspected metastatic retinal lesion of the right eye. Retinal thinning with cordon-like hyperreflective structures was seen on OCT. Neoplastic cells consistent with small cell carcinoma were identified in the vitreous sample. Those cells were thought to be similar to the previous biopsied cerebellar tumor specimen. OCT imaging, along with vitrectomy and retinal biopsy, may be useful in the evaluation of patients with suspected metastatic lesions of the retina. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Year:  2011        PMID: 22150598     DOI: 10.3928/15428877-20111201-02

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  4 in total

1.  Retinal metastasis from unknown primary: diagnosis, management, and clinicopathologic correlation.

Authors:  Kenneth J Taubenslag; Stephen J Kim; Albert Attia; Ty W Abel; Hilary Highfield Nickols; Kristin K Ancell; Anthony B Daniels
Journal:  Digit J Ophthalmol       Date:  2015-10-05

2.  [One Case about Primary Pulmonary Squamous Cell Carcinoma 
with Retinal Metastasis].

Authors:  Jinxia Liu; Xiqian Gao; Mindan Sun
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-09-20

3.  Multimodal imaging of retinal metastasis masquerading as an acute retinal necrosis.

Authors:  Fukutaro Mano; Stephen A LoBue; Kuo-Chung Chang; Tomiya Mano
Journal:  Int J Retina Vitreous       Date:  2018-11-21

4.  Presumed Retinal Metastasis from Lung Adenocarcinoma: A Case Report and Literature Review.

Authors:  Gökçen Özcan; Ahmet Kaan Gündüz; Ibadulla Mirzayev; Ayhan Sağlik
Journal:  Case Rep Ophthalmol Med       Date:  2021-06-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.